Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Tumor Cells

Circulating Tumor Cells

Date: Tuesday, 22 January 2013 - Wednesday, 23 January 2013
Location: San Diego, CA, USA

Keynote Speakers

Katharina Pachmann

Katharina Pachmann
Professor, University of Jena

Dario Marchetti

Dario Marchetti
Endowed Professor, Baylor College of Medicine


Our 2nd annual Circulating Tumour Cells 2012 conference is expanding on the interest expressed in the CTC sessions of our very popular Single Cell Analysis conferences.

With oncologists increasingly using CTCs to gather prognostic information on their patients, it is more and more apparent that CTCs can offer clinicians a non-invasive means of sampling for genetic markers, monitoring treatment responsiveness, aiding in treatment decision-making and indicating novel drug targets.
However, there are still issues and questions being raised about the clinical significance of CTCs, as well as the need to improve sensitivity, reproducibility and reliability of their use in disease monitoring. To solve these problems there is a real need for increased collaboration and understanding if the industry is to effectively use CTCs to improve cancer survival rates and provide significant cost-savings.

The Circulating Tumor Cells 2012 conference and exhibition offers delegates 2 days of world class speakers who are at the forefront of the field and whose talks will be exploring, as well as attempting to answer, some of these CTC questions.

Other conference tracks at this event include Cell Based Assays, Cell Culture, Cancer Stem Cells and Flow Cytometry.

Running alongside the conference will be an exhibition covering the latest technological advances and associated services within these fields.

Agenda Topics

  • CTCs as Prognostic or Predictive Biomarkers for Cancer
  • Early Cancer Detection
  • EMT in Cell Generation and Survival
  • Isolation and Analysis of CTCs: Emerging Technologies Impacting the Field
  • Methods of Enumeration of CTCs as a Predictor
  • Novel Methods for Detection and Profiling
  • Significance of CTCs in Various Types of Cancer: Liquid Tumors vs. Solid Tumors
  • The Formation and Markers for Circulating Tumor Cells
  • The use of Circulating Tumour Cells in Clinical Development
  • Understanding the Role of EMT in Metastasis

Sponsorship and Exhibition Opportunities

Exhibition Team,
+44 (0) 1206 501654

Confirmed Speakers to date

Jeff Chalmers, Director, The Ohio State University
Sam Hanash, Director, McCombs Institute for Cancer Detection and Treatment, University of Texas MD Anderson Cancer Center
David Hoon, Professor, Director Department of Translational Molecular Medicine, John Wayne Cancer Institute
Iman Jilani, Associate Director, Pfizer Inc
Anand Kolatkar, Researcher, Scripps Research Institute
Henry Lin, Graduate Student, University of California
Pamela Paris, Associate Professor, University of California San Francisco
Enal Razvi, Managing Director, Select Biosciences Inc
Andrew Rhim, Instructor of Medicine, University of Pennsylvania School of Medicine
Lidia Sambucetti, Senior Director, SRI International
Hsian-Rong Tseng, Professor, Crump Institute for Molecular Imaging, California NanoSystems Institute, University of California-Los Angeles
Jean-Louis Viovy, Group Leader, Institut Curie

Corporate Sponsors Media Sponsors Networking

Add to Calendar ▼2013-01-22 00:00:002013-01-23 00:00:00Europe/LondonCirculating Tumor